π₯ Health Dashboard β Carlos Blanco
Comprehensive Health Report | April 19, 2026 | Age 42 | Latest Labs: April 16, 2026
VO2 Max
42.2
Up from 39.1 β
Avg Steps
22,353
Extremely active
Avg Sleep
7h 30m
Eight Sleep 29-night avg
Resting HR
61 bpm
Apple Health avg
Body Fat
20.5%
DEXA Jan 2025
Total T
1,131
β24% β more controlled
LDL
133.4
β30.8% from 192.7! β
hs-CRP
<0.5
Excellent β low inflam
π©Έ Bloodwork Panel β Rythm Health, April 16, 2026 (vs March 20)
| Marker | Value | Reference | Status | Trend |
| LDL Cholesterol | 133.4 mg/dL | <130 | NEAR TARGET | ββ was 192.7 (-30.8%!) |
| ApoB | 108 mg/dL | <90 | IMPROVING | β was 137 (-21.2%) |
| Total Cholesterol | 213 mg/dL | <240 | NORMAL | β was 281 (-24%) |
| HDL | 53.4 mg/dL | >60 | DROPPED | β was 65.9 (-19% β οΈ) |
| Triglycerides | 131 mg/dL | <90 | ABOVE | β was 112 (+17%) |
| hs-CRP | <0.5 mg/L | <1.0 | EXCELLENT | β |
| Total Testosterone | 1,131 ng/dL | 250-1100 | BORDERLINE | β was >1500 (-24%) |
| Free Testosterone | 324.1 pg/mL | 35-155 | HIGH | β was 371 (-12%) |
| Estradiol (E2) | 47.8 pg/mL | <40 | IMPROVING | β was 58.9 (-18%) |
| TSH | 1.41 mIU/L | 0.5-4.5 | OPTIMAL | Stable (was 1.27) |
| Vitamin D | 62.7 ng/mL | 40-80 | OPTIMAL | Stable (was 64.4) |
| Ferritin | 200 ng/mL | 20-300 | OPTIMAL | β was 288 (-30.6%) |
| Fasting Insulin | 23.6 uIU/mL | 2-20 | ELEVATED | β was 7.5 |
| Glucose | 95 mg/dL | 65-99 | NORMAL | β |
| HOMA-IR | 5.65 | <2.0 | HIGH | Calculated |
| ALT | Normal | <50 | NORMAL | β was 57 |
ποΈ Body Composition β DEXA Scan, Jan 9, 2025
Total Body Fat
20.5%
Athletic range
Fat Mass
33.2 lbs
Of 161.8 lbs total
Visceral Fat
42.4 inΒ³
VAT volume
A/G Ratio
1.31
Abdominal pattern β οΈ
Bone Mineral
6.1 lbs
BMC total
| Region | % Fat | Lean Mass | Fat Mass |
| Arms | 12.9% | 16.8 lbs | 2.5 lbs |
| Legs | 17.0% | 40.0 lbs | 8.2 lbs |
| Trunk | 26.1% | 58.2 lbs | 20.5 lbs |
β€οΈ Cardiovascular
Resting HR
61 bpm
Apple Health avg
HRV (RMSSD)
34 ms
Low for age
Cardiac CT
RMI 1.2
Cleerly AI β low risk
Sleep HR
58 bpm
Eight Sleep avg
π΄ Sleep Dashboard β Eight Sleep (29-Night Averages)
Avg Duration
7h 30m
Target: 7-8h
Deep Sleep
79 min
18% of sleep
REM Sleep
95 min
21% of sleep
Sleep HRV
214 ms
Eight Sleep method
Last Night (Apr 19): 6.4h sleep | Deep: 26% (1.6h) | REM: 24% (1.5h) | HR: 51.6 bpm | HRV: 53.5 ms | Resp: 15.7/min
Sleep efficiency: 89% avg | Chronotype: late | Temp preference: cool
π₯ Metabolic Testing β PNOE, Jan 9, 2025
Fat Burning
77%
Fat utilization at rest
Breathing
96%
Coordination score
Lung Utilization
100%
Full capacity
HRV Score
94%
PNOE assessment
Non-Workout Cal
2,869
kcal/day
𧬠Genetics β 23andMe
Ancestry
99.5% Spanish (90.7% Andalusian/Asturian/Castilian, 6.2% Basque, 2.6% Portuguese)
Health Risk Variants
| Alzheimer's / Parkinson's | NO VARIANTS |
| Hereditary Heart Disease | NO VARIANTS |
| Macular Degeneration | FLAGGED |
| Celiac Disease | FLAGGED |
| Triglyceride Risk | FLAGGED |
| Prostate Cancer | FLAGGED |
Wellness Traits
Light sleeper genetically | Saturated fat sensitivity | Caffeine consumer (but slow metabolizer β CYP1A2 AC)
π· Imaging
Prenuvo Whole-Body MRI (Apr 2023 + Apr 2024)
- ONCO-RADS Category 2 β No Cancer
- Mild spinal degeneration (cervical, thoracic, lumbar) β stable
- L5/S1 disc bulge + 25% height loss + annular fissure β stable, monitor
- T6 hemangioma 0.9cm β benign, unchanged
- Prostate: 18.2 mL (normal)
- Next scan due: April 2026
Fountain Life Cardiac CT (Dec 2021)
- Cleerly AI: Max RMI 1.2 (borderline), very low soft plaque
- No repeat needed 2-3 years (next: 2024-2025)
π Supplement Protocol β Genetically Optimized (160+ SNPs)
βοΈ Morning β 17 Supplements with Breakfast
| # | Supplement | Dose | Why (Genetic Basis) |
| 1 | Omega-3 Fish Oil | 2,000mg | FADS1/FADS2 β can't convert plant omega-3 |
| 2 | CoQ10 (Ubiquinol) | 200mg | ACE DD + ENOS GT β vascular protection |
| 3 | Vitamin D3 | 5,000 IU | CYP2R1/GC/VDR triple impairment |
| 4 | Vitamin K2 (MK-7) | 200mcg | Calciumβbones not arteries (COL1A1 TT) |
| 5 | Curcumin (Meriva) | 500mg | IL-6 GC + IL-6R AC double inflammatory hit |
| 6 | NAC | 600mg | GSTM1 DELETED β missing Phase II detox |
| 7 | Methylated B-Complex | 1 cap | MTHFR 677 CT β 35% reduced folate |
| 8 | L-Tyrosine | 500mg | DRD2 TT β 30% fewer dopamine receptors |
| 9 | CDP-Choline | 500mg | MTHFD1 GA β high choline demand |
| 10 | Calcium Citrate | 500mg | COL1A1 TT β weaker bone matrix |
| 11 | Collagen Peptides | 10g | COL1A1 + MMP1 + GDF5 β weak collagen |
| 12 | Creatine Monohydrate | 5g | ACTN3 XX + cognitive support |
| 13 | L-Carnitine (ALCAR) | 1,000mg | 4 impaired fat-burning genes |
| 14 | DIM | 200mg | CYP19A1 TT β aromatase + E2 management |
| 15 | Calcium D-Glucarate | 500mg | UGT2B15 TG β estrogen/toxin clearance |
| 16 | Selenium | 200mcg | DIO2 TC β T4βT3 thyroid conversion |
| 17 | Glucosamine + Chondroitin | 1,500/1,200mg | GDF5 TT + COL1A1 TT β joint protection |
π Evening β 5 Supplements with Dinner
| # | Supplement | Dose | Why |
| 1 | Omega-3 (split dose) | 2,000mg | Total daily: 4g |
| 2 | Magnesium Glycinate | 400mg | ACE DD + GABA support + sleep |
| 3 | Curcumin (split dose) | 500mg | Total daily: 1,000mg |
| 4 | CoQ10 (split dose) | 200mg | Total daily: 400mg |
| 5 | Berberine | 500mg | IRS1 CT β insulin sensitivity + LDL |
π LDL/ApoB Reduction Protocol
Goal: LDL 192.7 β <130 | ApoB 137 β <90
Root Cause: TRT at >1,500 ng/dL upregulates hepatic lipase, reduces LDL receptor activity
| Week | Supplement | Dose | Expected LDL β |
| 1 | Citrus Bergamot | 1,000mg/day (500mg 2x) | 20-30% |
| 1 | Omega-3 Fish Oil | 2-4g EPA+DHA | TG β15-30% |
| 2 | Plant Sterols/Stanols | 2,000mg/day | 6-15% |
| 2 | Psyllium Husk Fiber | 10g/day (5g 2x) | 5-10% |
| 3 | Red Yeast Rice + CoQ10 | 1,200mg + 100mg | 15-25% |
π₯ Food Recommendations β Viome
π Superfoods (35)
- Almonds, Apple, Artichoke, Asparagus
- Black Beans, Blueberry, Broccoli
- Cinnamon, Cranberry, Garlic, Ginger
- Grapefruit, Grapes, Green Tea
- Kiwi, Olive Oil, Orange, Papaya
- Pineapple, Pistachio, Pomegranate
- Salmon, Spinach, Turmeric
β Minimize / Avoid
- π§ Aged cheeses (parmesan, cheddar)
- π₯ Cured meats (salami, prosciutto)
- π· Red wine, champagne, beer
- π₯ Fermented foods (kimchi, sauerkraut)
- π Canned/smoked fish (fresh only!)
- π₯« Leftover food (histamine builds)
- β‘ Energy drinks (slow caffeine metabolizer)
π
Upcoming & Action Items
| WIN | LDL 192.7 β 133.4 (-30.8%) in 4 weeks! Protocol WORKING. Continue and recheck June 2026 |
| IMPROVING | TRT dose adjusted β T: 1131 (was >1500), E2: 47.8 (was 58.9). Lipids responding |
| SOON | Prenuvo WB-MRI #3 β due April 2026 |
| SOON | Recheck Lp(a) β last done 2021 |
| SOON | Recheck Ferritin β was 518, now 288 (monitor hemochromatosis) |
| WATCH | HDL dropped 65.9 β 53.4 (-19%). TGs up 112 β 131 (+17%). Monitor next labs |
| MONITOR | L5/S1 disc bulge β stable, annual check |
| MONITOR | Daylight exposure only 4.6 min/day β critically low |
| TRACK | VO2 Max trending up (39.1 β 42.2) β keep it going |
Health Dashboard β Carlos Blanco | Generated April 19, 2026 | Sources: Rythm Health Labs, Eight Sleep, Apple Health, 23andMe, Prenuvo, Fountain Life, DEXA, PNOE, Viome